A Cost-Effectiveness Study of Stereotactic-Body Radiation Therapy Compared to Surgery in Patients with Early NonSmall Cell Lung Cancer, from the Perspective of the Brazilian Private Health-Care System

被引：0
|
作者：
Santos, M. A. [1 ,2 ]
Oliveira e Silva, L. F. [3 ]
Reis Neto, J. P. [4 ]
Bernardi, B. [5 ]
Lee, D. [6 ]
机构：
[1] EORTC Qual Life Grp, Brussels, Belgium
[2] ALATRO Latin Amer Soc Radiat Oncol, Brasilia, DF, Brazil
[3] CONFIAR Radiotherapy, Goiania, Go, Brazil
[4] CAPESESP, Rio De Janeiro, Brazil
[5] Varian, Milpitas, CA USA
[6] Varian Med Syst, Washington, DC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2870
引用
收藏
页码：E389 / E389
页数：1
相关论文
共 50 条
  • [41] Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
    Kenta Watanabe
    Kuniaki Katsui
    Soichiro Sugiyama
    Kotaro Yoshio
    Masahiro Kuroda
    Takao Hiraki
    Katsuyuki Kiura
    Yoshinobu Maeda
    Shinichi Toyooka
    Susumu Kanazawa
    Radiation Oncology, 16
  • [42] Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
    Watanabe, Kenta
    Katsui, Kuniaki
    Sugiyama, Soichiro
    Yoshio, Kotaro
    Kuroda, Masahiro
    Hiraki, Takao
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [43] Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients
    Samson, Pamela
    Keogan, Kathleen
    Crabtree, Traves
    Colditz, Graham
    Broderick, Stephen
    Puri, Varun
    Meyers, Bryan
    LUNG CANCER, 2017, 103 : 6 - 10
  • [44] Cost-Effectiveness Study Comparing Imatinib with Interferon-α for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Health-Care System Perspective (CPHSP)
    Chen, Zi
    Wang, Chun
    Xu, Xiaoping
    Feng, Weiwei
    VALUE IN HEALTH, 2009, 12 : S85 - S88
  • [45] Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
    Blom, Erik F.
    ten Haaf, Kevin
    Arenberg, Douglas A.
    de Koning, Harry J.
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [46] To determine the cost-effectiveness of pemetrexed (PEM) compared to current standards of care in 2nd-line advanced non-small cell lung cancer (NSCLC) from the UK National Health Service (NHS) perspective
    Bhalla, S.
    Hibbert, C.
    Watkins, J.
    Beard, S.
    Cetty, M.
    Arellano, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective
    Hu, Xiaohan
    Hay, Joel W.
    LUNG CANCER, 2018, 123 : 166 - 171
  • [48] COST-EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH ASYMPTOMATIC TO MILD HEART FAILURE BASED ON THE EUROPEAN COHORT OF THE REVERSE STUDY FROM THE SPANISH HEALTH SYSTEM PERSPECTIVE
    Quesada, A.
    Almenar, L.
    Diaz Molina, B.
    Crespo, C.
    Marti, B.
    Mealing, S.
    Linde, C.
    Daubert, C.
    VALUE IN HEALTH, 2011, 14 (07) : A249 - A249
  • [49] Cost-Effectiveness of Optimized Background Therapy Plus Maraviroc for Previously Treated Patients With R5 HIV-1 Infection From the Perspective of the Spanish Health Care System
    Moreno, Santiago
    Gonzalez, Juan
    Lekander, Ingrid
    Marti, Belen
    Oyagueez, Itziar
    Sanchez-de la Rosa, Rainel
    Angel Casado, Miguel
    CLINICAL THERAPEUTICS, 2010, 32 (13) : 2232 - 2245
  • [50] Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System
    Criss, Steven D.
    Mooradian, Meghan J.
    Sheehan, Deirdre F.
    Zubiri, Leyre
    Lumish, Melissa A.
    Gainor, Justin F.
    Reynolds, Kerry L.
    Kong, Chung Yin
    JAMA ONCOLOGY, 2019, 5 (03) : 358 - 365
12345